Published in Infect Immun on April 01, 2003
The complete genome sequence and comparative genome analysis of the high pathogenicity Yersinia enterocolitica strain 8081. PLoS Genet (2006) 3.33
The type II secretion system: biogenesis, molecular architecture and mechanism. Nat Rev Microbiol (2012) 1.96
Application of comparative phylogenomics to study the evolution of Yersinia enterocolitica and to identify genetic differences relating to pathogenicity. J Bacteriol (2006) 1.29
Complete genome sequence of a Yersinia enterocolitica "Old World" (3/O:9) strain and comparison with the "New World" (1B/O:8) strain. J Clin Microbiol (2011) 1.27
Comparative analysis of the Photorhabdus luminescens and the Yersinia enterocolitica genomes: uncovering candidate genes involved in insect pathogenicity. BMC Genomics (2008) 1.20
Identification of Erwinia amylovora genes induced during infection of immature pear tissue. J Bacteriol (2005) 1.15
Pathogenesis of Y. enterocolitica and Y. pseudotuberculosis in Human Yersiniosis. J Pathog (2011) 1.05
Investigation of the enteric pathogenic potential of oral Campylobacter concisus strains isolated from patients with inflammatory bowel disease. PLoS One (2012) 1.03
Comparative analysis of Klebsiella pneumoniae genomes identifies a phospholipase D family protein as a novel virulence factor. BMC Biol (2014) 0.96
Shotgun sequencing of Yersinia enterocolitica strain W22703 (biotype 2, serotype O:9): genomic evidence for oscillation between invertebrates and mammals. BMC Genomics (2011) 0.95
Synchronous gene expression of the Yersinia enterocolitica Ysa type III secretion system and its effectors. J Bacteriol (2009) 0.90
Type II secretion in Yersinia-a secretion system for pathogenicity and environmental fitness. Front Cell Infect Microbiol (2012) 0.86
Molecular characterization of human clinical isolates of Yersinia enterocolitica bioserotype 1B/O8 in Poland: emergence and dissemination of three highly related clones. J Clin Microbiol (2009) 0.82
Transcriptomic Analysis of Yersinia enterocolitica Biovar 1B Infecting Murine Macrophages Reveals New Mechanisms of Extracellular and Intracellular Survival. Infect Immun (2015) 0.81
Acinetobacter baumannii Is Dependent on the Type II Secretion System and Its Substrate LipA for Lipid Utilization and In Vivo Fitness. J Bacteriol (2015) 0.80
YtxR acts as an overriding transcriptional off switch for the Yersinia enterocolitica Ysc-Yop type 3 secretion system. J Bacteriol (2008) 0.80
Serogroup-related escape of Yersinia enterocolitica YopE from degradation by the ubiquitin-proteasome pathway. Infect Immun (2007) 0.80
The Yersinia enterocolitica Ysa type III secretion system is expressed during infections both in vitro and in vivo. Microbiologyopen (2013) 0.78
Prevalence of Very Low Numbers of Potential Pathogenic Isolates of Yersiniaenterocolitica and Yersinia intermedia in Traditional Fast Foods of India. Indian J Microbiol (2011) 0.77
Differential expression of pathogenicity- and virulence-related genes of Xanthomonas axonopodis pv. citri under copper stress. Genet Mol Biol (2010) 0.76
Differential Regulation of the Surface-Exposed and Secreted SslE Lipoprotein in Extraintestinal Pathogenic Escherichia coli. PLoS One (2016) 0.75
Characterization and Comparative Overview of Complete Sequences of the First Plasmids of Pandoraea across Clinical and Non-clinical Strains. Front Microbiol (2016) 0.75
Expanding Role of Type II Secretion in Bacterial Pathogenesis and Beyond. Infect Immun (2017) 0.75
The YsrS Paralog DygS Has the Capacity To Activate Expression of the Yersinia enterocolitica Ysa Type III Secretion System. J Bacteriol (2016) 0.75
Pullulanase Is Necessary for the Efficient Intracellular Growth of Francisella tularensis. PLoS One (2016) 0.75
Evolutionary study of Yersinia genomes deciphers emergence of human pathogenic species. Sci Rep (2016) 0.75
Studies on transformation of Escherichia coli with plasmids. J Mol Biol (1983) 116.81
Type III protein secretion systems in bacterial pathogens of animals and plants. Microbiol Mol Biol Rev (1998) 17.27
Yersinia pestis--etiologic agent of plague. Clin Microbiol Rev (1997) 14.63
Genome sequence of Yersinia pestis, the causative agent of plague. Nature (2001) 14.36
Characterization of plasmids and plasmid-associated determinants of Yersinia enterocolitica pathogenesis. Infect Immun (1981) 13.80
Suppression subtractive hybridization: a method for generating differentially regulated or tissue-specific cDNA probes and libraries. Proc Natl Acad Sci U S A (1996) 11.80
Positive selection vectors for allelic exchange. Gene (1996) 5.97
Pathogenecity of Yersinia enterocolitica for mice. Infect Immun (1975) 5.50
Virulence-associated plasmids from Yersinia enterocolitica and Yersinia pestis. J Bacteriol (1981) 5.11
The great escape: structure and function of the autotransporter proteins. Trends Microbiol (1998) 4.72
Homology between virF, the transcriptional activator of the Yersinia virulence regulon, and AraC, the Escherichia coli arabinose operon regulator. J Bacteriol (1989) 3.89
Biology of type II secretion. Mol Microbiol (2001) 3.31
Prevalence of the "high-pathogenicity island" of Yersinia species among Escherichia coli strains that are pathogenic to humans. Infect Immun (1998) 3.17
A new pathway for the secretion of virulence factors by bacteria: the flagellar export apparatus functions as a protein-secretion system. Proc Natl Acad Sci U S A (1999) 2.99
Cloning and expression in Escherichia coli of the Klebsiella pneumoniae genes for production, surface localization and secretion of the lipoprotein pullulanase. EMBO J (1987) 2.81
Type II secretion and pathogenesis. Infect Immun (2001) 2.75
General secretion pathway (eps) genes required for toxin secretion and outer membrane biogenesis in Vibrio cholerae. J Bacteriol (1997) 2.69
The bacterial flagellum: reversible rotary propellor and type III export apparatus. J Bacteriol (1999) 2.48
Analysis of expression and thermoregulation of the Yersinia pseudotuberculosis inv gene with hybrid proteins. Infect Immun (1988) 2.36
Macromolecular assembly and secretion across the bacterial cell envelope: type II protein secretion systems. J Mol Biol (1998) 2.35
The high-pathogenicity island of Yersinia pseudotuberculosis can be inserted into any of the three chromosomal asn tRNA genes. Mol Microbiol (1998) 2.31
Growth phase and low pH affect the thermal regulation of the Yersinia enterocolitica inv gene. Mol Microbiol (1994) 2.26
The yersiniabactin biosynthetic gene cluster of Yersinia enterocolitica: organization and siderophore-dependent regulation. J Bacteriol (1998) 2.18
Molecular mechanisms of bacterial virulence: type III secretion and pathogenicity islands. Emerg Infect Dis (1997) 2.17
Cloned Erwinia chrysanthemi out genes enable Escherichia coli to selectively secrete a diverse family of heterologous proteins to its milieu. Proc Natl Acad Sci U S A (1991) 1.92
YbtP and YbtQ: two ABC transporters required for iron uptake in Yersinia pestis. Mol Microbiol (1999) 1.90
Protein secretion by Gram-negative bacterial ABC exporters--a review. Gene (1997) 1.86
Expression of the endogenous type II secretion pathway in Escherichia coli leads to chitinase secretion. EMBO J (2000) 1.82
The invasion-associated type-III protein secretion system in Salmonella--a review. Gene (1997) 1.74
The 102-kilobase unstable region of Yersinia pestis comprises a high-pathogenicity island linked to a pigmentation segment which undergoes internal rearrangement. J Bacteriol (1998) 1.70
A chromosomally encoded type III secretion pathway in Yersinia enterocolitica is important in virulence. Mol Microbiol (2000) 1.66
Molecular cloning, iron-regulation and mutagenesis of the irp2 gene encoding HMWP2, a protein specific for the highly pathogenic Yersinia. Mol Microbiol (1992) 1.66
The ail gene of Yersinia enterocolitica has a role in the ability of the organism to survive serum killing. Infect Immun (1993) 1.65
Chromosomal irp2 gene in Yersinia: distribution, expression, deletion and impact on virulence. Microb Pathog (1993) 1.63
Biochemistry of type IV secretion. Curr Opin Microbiol (1999) 1.61
YplA is exported by the Ysc, Ysa, and flagellar type III secretion systems of Yersinia enterocolitica. J Bacteriol (2002) 1.59
Identification of virulence genes in a pathogenic strain of Pseudomonas aeruginosa by representational difference analysis. J Bacteriol (2002) 1.58
Secretion of virulence determinants by the general secretory pathway in gram-negative pathogens: an evolving story. Microbes Infect (2000) 1.53
Characterization of the ysa pathogenicity locus in the chromosome of Yersinia enterocolitica and phylogeny analysis of type III secretion systems. J Mol Evol (2002) 1.45
A nosocomial outbreak of diarrheal disease due to Yersinia enterocolitica serotype 0:5, biotype 1. J Infect Dis (1982) 1.33
Channel formation by FhaC, the outer membrane protein involved in the secretion of the Bordetella pertussis filamentous hemagglutinin. J Biol Chem (1999) 1.31
LcrF is the temperature-regulated activator of the yadA gene of Yersinia enterocolitica and Yersinia pseudotuberculosis. J Bacteriol (1992) 1.25
Isolation and characterization of a second exe operon required for extracellular protein secretion in Aeromonas hydrophila. J Bacteriol (1994) 1.11
Use of representational difference analysis to identify genomic differences between pathogenic strains of Vibrio cholerae. Infect Immun (1998) 1.11
Genomic subtractive hybridization and selective capture of transcribed sequences identify a novel Salmonella typhimurium fimbrial operon and putative transcriptional regulator that are absent from the Salmonella typhi genome. Infect Immun (1999) 1.05
Plasmids and pathogenicity islands of Yersinia. Curr Top Microbiol Immunol (2002) 0.89
The ChiA (YheB) protein of Escherichia coli K-12 is an endochitinase whose gene is negatively controlled by the nucleoid-structuring protein H-NS. Mol Microbiol (2000) 0.88
Molecular organization of the xcp gene cluster in Pseudomonas putida: absence of an xcpX (gspK) homologue. Gene (1999) 0.84
Representational difference analysis uncovers a novel IS10-like insertion element unique to pathogenic strains of Yersinia enterocolitica. FEMS Microbiol Lett (2002) 0.78
T cell interleukin-17 induces stromal cells to produce proinflammatory and hematopoietic cytokines. J Exp Med (1996) 8.59
Interleukin 10 is a potent growth and differentiation factor for activated human B lymphocytes. Proc Natl Acad Sci U S A (1992) 6.37
The product of a newly identified gene, gInF, is required for synthesis of glutamine synthetase in Salmonella. Proc Natl Acad Sci U S A (1977) 5.19
Insights into the evolution of Yersinia pestis through whole-genome comparison with Yersinia pseudotuberculosis. Proc Natl Acad Sci U S A (2004) 5.09
Nitrogen control in Salmonella: regulation by the glnR and glnF gene products. Proc Natl Acad Sci U S A (1979) 4.79
Coronary angioplasty with or without stent implantation for acute myocardial infarction. Stent Primary Angioplasty in Myocardial Infarction Study Group. N Engl J Med (1999) 4.37
Improvement of retardates' mealtime behaviors by timeout procedures using multiple baseline techniques. J Appl Behav Anal (1970) 3.97
Genetically manipulated virulence of Yersinia enterocolitica. Infect Immun (1984) 3.81
A plasmid of enterohemorrhagic Escherichia coli O157:H7 is required for expression of a new fimbrial antigen and for adhesion to epithelial cells. Infect Immun (1987) 3.76
Long-term human B cell lines dependent on interleukin-4 and antibody to CD40. Science (1991) 3.56
Comparison of primary coronary angioplasty and intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review. JAMA (1997) 3.51
Frequent loss of Shiga-like toxin genes in clinical isolates of Escherichia coli upon subcultivation. Infect Immun (1992) 3.47
Structure and sequence analysis of Yersinia YadA and Moraxella UspAs reveal a novel class of adhesins. EMBO J (2000) 3.23
Prevalence of the "high-pathogenicity island" of Yersinia species among Escherichia coli strains that are pathogenic to humans. Infect Immun (1998) 3.17
Cytokine-induced proliferation and immunoglobulin production of human B lymphocytes triggered through their CD40 antigen. J Exp Med (1991) 3.04
Double immunofluorescence microscopic technique for accurate differentiation of extracellularly and intracellularly located bacteria in cell culture. J Clin Microbiol (1985) 2.72
A ribonucleotide reductase homolog of cytomegalovirus and endothelial cell tropism. Science (2001) 2.70
Development of PCR for screening of enteroaggregative Escherichia coli. J Clin Microbiol (1995) 2.66
Searching for autolysin functions. Characterization of a pneumococcal mutant deleted in the lytA gene. Eur J Biochem (1986) 2.58
The training and generalization of a conversational speech form in nonverbal retardates. J Appl Behav Anal (1974) 2.55
Isolation of a temperate bacteriophage encoding the type III effector protein SopE from an epidemic Salmonella typhimurium strain. Proc Natl Acad Sci U S A (1999) 2.51
Horizontal gene transfer of the Escherichia coli pap and prs pili operons as a mechanism for the development of tissue-specific adhesive properties. Mol Microbiol (1992) 2.50
Clinical characteristics and outcome of patients with early (<2 h), intermediate (2-4 h) and late (>4 h) presentation treated by primary coronary angioplasty or thrombolytic therapy for acute myocardial infarction. Eur Heart J (2002) 2.49
Coronary artery anomalies: a review of more than 10,000 patients from the Clayton Cardiovascular Laboratories. Tex Heart Inst J (1988) 2.48
Shiga-like toxin II-related cytotoxins in Citrobacter freundii strains from humans and beef samples. Infect Immun (1993) 2.47
Immune responses to Yersinia enterocolitica in susceptible BALB/c and resistant C57BL/6 mice: an essential role for gamma interferon. Infect Immun (1994) 2.45
Normal flow (TIMI-3) before mechanical reperfusion therapy is an independent determinant of survival in acute myocardial infarction: analysis from the primary angioplasty in myocardial infarction trials. Circulation (2001) 2.43
Clonal structure and pathogenicity of Shiga-like toxin-producing, sorbitol-fermenting Escherichia coli O157:H-. J Clin Microbiol (1993) 2.43
Immunochemical analysis of plasmid-encoded proteins released by enteropathogenic Yersinia sp. grown in calcium-deficient media. Infect Immun (1986) 2.42
Binding to collagen by Yersinia enterocolitica and Yersinia pseudotuberculosis: evidence for yopA-mediated and chromosomally encoded mechanisms. J Bacteriol (1989) 2.36
Construction of a mobilizable Yersinia enterocolitica virulence plasmid. J Bacteriol (1983) 2.33
Reduced replication of Toxoplasma gondii is necessary for induction of bradyzoite-specific antigens: a possible role for nitric oxide in triggering stage conversion. Infect Immun (1994) 2.26
Structural organization of virulence-associated plasmids of Yersinia pestis. J Bacteriol (1998) 2.22
Plasmids of human strains of Yersinia enterocolitica: molecular relatedness and possible importance for pathogenesis. J Infect Dis (1983) 2.20
Fas ligation induces apoptosis of CD40-activated human B lymphocytes. J Exp Med (1995) 2.19
The yersiniabactin biosynthetic gene cluster of Yersinia enterocolitica: organization and siderophore-dependent regulation. J Bacteriol (1998) 2.18
Differentiation in virulence patterns of Escherichia coli possessing eae genes. Med Microbiol Immunol (1994) 2.16
The pesticin receptor of Yersinia enterocolitica: a novel virulence factor with dual function. Mol Microbiol (1994) 2.15
Puromycin-based purification of rat brain capillary endothelial cell cultures. Effect on the expression of blood-brain barrier-specific properties. J Neurochem (2005) 2.14
Development of rRNA-targeted PCR and in situ hybridization with fluorescently labelled oligonucleotides for detection of Yersinia species. J Clin Microbiol (1998) 2.13
Intestinal metaplasia of human stomach displays distinct patterns of mucin (MUC1, MUC2, MUC5AC, and MUC6) expression. Cancer Res (1999) 2.09
Variants of Shiga-like toxin II constitute a major toxin component in Escherichia coli O157 strains from patients with haemolytic uraemic syndrome. J Med Microbiol (1994) 2.08
Randomised comparison of implantation of heparin-coated stents with balloon angioplasty in selected patients with coronary artery disease (Benestent II) Lancet (1998) 2.06
Long-term shedding and clonal turnover of enterohemorrhagic Escherichia coli O157 in diarrheal diseases. J Clin Microbiol (1995) 2.04
[HYGEA (Hygiene in gastroenterology--endoscope reprocessing): Study on quality of reprocessing flexible endoscopes in hospitals and in the practice setting]. Z Gastroenterol (2002) 1.93
Virulence of Yersinia enterocolitica is closely associated with siderophore production, expression of an iron-repressible outer membrane polypeptide of 65,000 Da and pesticin sensitivity. Mol Microbiol (1993) 1.93
The spectrum of immune responses to Campylobacter jejuni and glycoconjugates in Guillain-Barré syndrome and in other neuroimmunological disorders. Ann Neurol (1993) 1.92
Specific and rapid detection by fluorescent in situ hybridization of bacteria in clinical samples obtained from cystic fibrosis patients. J Clin Microbiol (2000) 1.91
Substitution of two histidine residues in YadA protein of Yersinia enterocolitica abrogates collagen binding, cell adherence and mouse virulence. Mol Microbiol (1995) 1.91
Toll-like receptor (TLR) 2 and TLR4 are essential for Aspergillus-induced activation of murine macrophages. Cell Microbiol (2003) 1.86
Detection of Campylobacter pyloridis in patients with antrum gastritis and peptic ulcers by culture, complement fixation test, and immunoblot. J Clin Microbiol (1986) 1.85
Interaction of Yersinia enterocolitica with macrophages leads to macrophage cell death through apoptosis. Infect Immun (1997) 1.85
Persistence of Yersinia enterocolitica in man. Infection (1988) 1.83
Phage-associated cytotoxin production by and enteroadhesiveness of enteropathogenic Escherichia coli isolated from infants with diarrhea in West Germany. J Infect Dis (1987) 1.79
High incidence of serum antibodies to Escherichia coli O157 lipopolysaccharide in children with hemolytic-uremic syndrome. J Pediatr (1991) 1.78
Cloning and characterization of a bradyzoite-specifically expressed gene (hsp30/bag1) of Toxoplasma gondii, related to genes encoding small heat-shock proteins of plants. Mol Microbiol (1995) 1.75
IL-18 (IFN-gamma-inducing factor) regulates early cytokine production in, and promotes resolution of, bacterial infection in mice. J Immunol (1998) 1.73
In vivo neutralization of tumor necrosis factor-alpha and interferon-gamma abrogates resistance to Yersinia enterocolitica infection in mice. Med Microbiol Immunol (1992) 1.73
Induction of bradyzoite-specific Toxoplasma gondii antigens in gamma interferon-treated mouse macrophages. Infect Immun (1993) 1.72
Differential contribution of Yersinia enterocolitica virulence factors to evasion of microbicidal action of neutrophils. Infect Immun (1996) 1.69
Prevalence of attaching and effacing Escherichia coli in stool samples from patients and controls. Zentralbl Bakteriol (1994) 1.69
Abiotrophia elegans sp. nov., a possible pathogen in patients with culture-negative endocarditis. J Clin Microbiol (1998) 1.68
Plasmid-encoded outer membrane protein YadA mediates specific binding of enteropathogenic yersiniae to various types of collagen. Infect Immun (1992) 1.68
High-pathogenicity island of Yersinia pestis in enterobacteriaceae isolated from blood cultures and urine samples: prevalence and functional expression. J Infect Dis (2000) 1.66
T lymphocytes mediate protection against Yersinia enterocolitica in mice: characterization of murine T-cell clones specific for Y. enterocolitica. Infect Immun (1992) 1.66
Rapid and specific detection of Helicobacter pylori macrolide resistance in gastric tissue by fluorescent in situ hybridisation. Gut (2000) 1.62
Mechanism of YadA-mediated serum resistance of Yersinia enterocolitica serotype O3. Infect Immun (1992) 1.61
The clinical syndrome of atrial myxoma. JAMA (1974) 1.60
Experimental Yersinia enterocolitica infection in euthymic and T-cell-deficient athymic nude C57BL/6 mice: comparison of time course, histomorphology, and immune response. Infect Immun (1993) 1.60
Early systolic closure of the aortic valve in patients with hypertrophic subaortic stenosis and discrete subaortic stenosis. Correlation with preoperative and postoperative hemodynamics. Am J Cardiol (1978) 1.60
Correlation between functional and structural assessments of the optic nerve and retina in multiple sclerosis patients. Neurophysiol Clin (2010) 1.59
[Nasogastric tube: intratracheal malposition and entrapment in a bronchial suture]. Ann Fr Anesth Reanim (1998) 1.59
Pneumocystis carinii carriage in immunocompetent patients with primary pulmonary disorders as detected by single or nested PCR. J Clin Microbiol (1999) 1.58
Idiotype identity in a MALT-type lymphoma and B cells in Helicobacter pylori associated chronic gastritis. Lab Invest (1994) 1.58
Experimental Yersinia infection of human synovial cells: persistence of live bacteria and generation of bacterial antigen deposits including "ghosts," nucleic acid-free bacterial rods. Infect Immun (1996) 1.57
Cloning and sequencing of a Shiga-like toxin II-related gene from Escherichia coli O157:H7 strain 7279. Zentralbl Bakteriol (1992) 1.56
An integrated metric physical map of human chromosome 19. Nat Genet (1995) 1.54
Early gamma interferon mRNA expression is associated with resistance of mice against Yersinia enterocolitica. Infect Immun (1994) 1.53
Chronic eosinophilic pneumonia as a presenting feature of Churg-Strauss syndrome. Eur Respir J (1994) 1.53
The cytotoxin YopT of Yersinia enterocolitica induces modification and cellular redistribution of the small GTP-binding protein RhoA. J Biol Chem (1999) 1.52
Molecular approaches to diagnosis of pulmonary diseases due to Mycoplasma pneumoniae. J Clin Microbiol (1998) 1.52
Transverse myelitis associated with Mycoplasma pneumoniae infection. Clin Infect Dis (1998) 1.50
HLA-B27 as a relative risk factor in ankylosing enthesopathy in transgenic mice. Hum Immunol (1995) 1.49
Nucleotide sequence and structural organization of Yersinia pestis insertion sequence IS100. FEMS Microbiol Lett (1994) 1.49
Tuberculosis skin testing, anergy and protein malnutrition in Peru. Int J Tuberc Lung Dis (2005) 1.48
Aortocoronary saphenous vein bypass. Results in 1,492 patients, with particular reference to patients with complicating features. Ann Thorac Surg (1973) 1.47
Passive immunity to infection with Yersinia spp. mediated by anti-recombinant V antigen is dependent on polymorphism of V antigen. Infect Immun (1997) 1.46
Identification of a virulence-associated antigen of Toxoplasma gondii by use of a mouse monoclonal antibody. Infect Immun (1991) 1.45
Interleukin (IL)-10 and IL-6 are produced in vivo by non-Hodgkin's lymphoma cells and act as cooperative growth factors. Cancer Res (1996) 1.45
Natalizumab is effective as second line therapy in the treatment of relapsing remitting multiple sclerosis. Eur J Neurol (2009) 1.44
Comparison of MB/BacT and BACTEC 460 TB systems for recovery of mycobacteria in a routine diagnostic laboratory. J Clin Microbiol (1999) 1.43
Yersinia outer protein P of Yersinia enterocolitica simultaneously blocks the nuclear factor-kappa B pathway and exploits lipopolysaccharide signaling to trigger apoptosis in macrophages. J Immunol (2001) 1.41
Outer membrane protein YadA of enteropathogenic yersiniae mediates specific binding to cellular but not plasma fibronectin. Infect Immun (1993) 1.41
Risk factors associated with preterm delivery after fetoscopic laser ablation for twin-twin transfusion syndrome. Ultrasound Obstet Gynecol (2014) 1.40